Galapagos NV - American Depositary Shares (GLPG)

Last Price26.78

Change+0.00 (0.00%)

NASDAQ · Last Trade: May 2nd, 5:11 AM EDT

Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications

Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell...

Via Newsfile · May 30, 2024

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline

- First participant dosed in Phase 1/2 PROSPER trial of FMC-376 in KRASG12C Cancers

By Frontier Medicines · Via GlobeNewswire · February 22, 2024